Invesco Ltd. Acquires 73,157 Shares of Pediatrix Medical Group, Inc. $MD

Key Points

• Invesco Ltd. has increased its holdings in Pediatrix Medical Group, Inc. by 9.3%, acquiring 73,157 shares during the 1st quarter, bringing its total ownership to approximately 1.00% of the company, valued at around $12.5 million.
• Other institutional investors have also significantly increased their positions in Pediatrix, with investments from firms like GAMMA Investing LLC increasing their stake by 219.5% during the same period.
• Pediatrix Medical Group recently reported $0.53 EPS for the quarter, surpassing analysts' expectations, although the company's revenue declined 7.1% year-over-year.

Invesco Ltd. increased its position in Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 9.3% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 863,269 shares of the company's stock after buying an additional 73,157 shares during the quarter. Invesco Ltd. owned 1.00% of Pediatrix Medical Group worth $12,509,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently modified their holdings of the business. GAMMA Investing LLC increased its holdings in Pediatrix Medical Group by 219.5% in the first quarter. GAMMA Investing LLC now owns 2,569 shares of the company's stock valued at $37,000 after purchasing an additional 1,765 shares during the period. Tower Research Capital LLC TRC lifted its stake in shares of Pediatrix Medical Group by 218.0% in the fourth quarter. Tower Research Capital LLC TRC now owns 7,445 shares of the company's stock worth $98,000 after acquiring an additional 5,104 shares during the period. Squarepoint Ops LLC acquired a new position in shares of Pediatrix Medical Group in the fourth quarter worth approximately $132,000. Sherbrooke Park Advisers LLC bought a new stake in Pediatrix Medical Group in the fourth quarter valued at approximately $136,000. Finally, Empirical Financial Services LLC d.b.a. Empirical Wealth Management acquired a new stake in Pediatrix Medical Group during the 1st quarter valued at approximately $159,000. Institutional investors own 97.71% of the company's stock.

Pediatrix Medical Group Stock Down 0.3%

Pediatrix Medical Group stock traded down $0.05 during trading on Tuesday, hitting $17.01. 811,712 shares of the company were exchanged, compared to its average volume of 911,081. The company has a market capitalization of $1.48 billion, a P/E ratio of 13.19 and a beta of 1.21. The business's 50 day moving average is $13.90 and its 200 day moving average is $13.98. Pediatrix Medical Group, Inc. has a 52 week low of $10.06 and a 52 week high of $17.67. The company has a current ratio of 1.80, a quick ratio of 1.80 and a debt-to-equity ratio of 0.70.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $0.53 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.42 by $0.11. Pediatrix Medical Group had a net margin of 5.66% and a return on equity of 18.94%. The firm had revenue of $468.84 million for the quarter, compared to the consensus estimate of $464.37 million. During the same period in the previous year, the firm earned $0.34 EPS. The business's revenue for the quarter was down 7.1% compared to the same quarter last year. Analysts predict that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current year.

Analysts Set New Price Targets

MD has been the topic of a number of recent analyst reports. Zacks Research upgraded shares of Pediatrix Medical Group to a "strong-buy" rating in a research report on Monday, August 11th. UBS Group lifted their target price on shares of Pediatrix Medical Group from $16.00 to $16.50 and gave the stock a "neutral" rating in a research note on Thursday, August 14th. Finally, Macquarie upped their price target on shares of Pediatrix Medical Group from $19.00 to $20.00 and gave the company an "outperform" rating in a research report on Thursday, May 8th. One investment analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and four have assigned a Hold rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $16.75.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.